MicroRNA-323-3p: A new biomarker and potential therapeutic target for rheumatoid arthritis

Rheumatology International

Volumn 34, Issue 5, 2014, Pages 721-722

  Xu, Tao ^a   Huang, Cheng ^a   Chen, Zhaolin ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; DICKKOPF 1 PROTEIN; LITHIUM SALT; MICRORNA; MICRORNA 146A; MICRORNA 221; MICRORNA 222; MICRORNA 323 3P; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; GENETIC MARKER; MIRN323 MICRORNA, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE EROSION; BONE REMODELING; CARTILAGE CELL; CARTILAGE MATRIX; CELL TYPE; DEGRADATION; DISEASE ASSOCIATION; EPIGENETICS; FIBROBLAST; GENETIC VARIABILITY; HUMAN; HYPERPLASIA; JOINT DESTRUCTION; NONHUMAN; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; ARTHRITIS, RHEUMATOID; DISEASE MODEL; GENETIC MARKER; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; GENETIC MARKERS; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901334763     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2767-3     Document Type: Article

References (7)

1. Duroux-Richard I, Jorgensen C, Apparailly F (2012) What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum 64(1):11-20. doi:10.1002/art.30651
2. Pandis I, Ospelt C, Karagianni N, Denis MC, Reczko M, Camps C, Hatzigeorgiou AG, Ragoussis J, Gay S, Kollias G (2012) Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 71(10):1716-1723. doi:10.1136/annrheumdis-2011-200803
3. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10(4):R101. doi:10.1186/ar2493
4. de Rooy DP, Yeremenko NG, Wilson AG, Knevel R, Lindqvist E, Saxne T, Krabben A, Leijsma MK, Daha NA, Tsonaka S, Zhernakova A, Houwing-Duistermaat JJ, Huizinga TW, Toes RE, Baeten DL, Brouwer E, van der Helm-van Mil AH (2013) Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann Rheum Dis 72(5):769-775. doi:10.1136/annrheumdis-2012-202184
5. Walsh NC, Gravallese EM (2010) Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 233(1):301-312. doi:10.1111/j.0105-2896.2009. 00857.x
6. Ammari M, Jorgensen C, Apparailly F (2013) Impact of microRNAs on the understanding and treatment of rheumatoid arthritis. Curr Opin Rheumatol 25(2):225-233. doi:10.1097/BOR.0b013e32835d8385
7. Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M (2011) The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 63(6):1582-1590. doi:10.1002/art.30321